ProCE Banner Activity

Barriers to HIV Prevention: More Than Just COVID-19

Clinical Thought
Learn how we adapted to meet patients’ needs during the COVID-19 pandemic at a university-affiliated clinic in the Southeastern United States and why we must continue to address the HIV prevention service barriers that many vulnerable communities face regardless of the limitations the pandemic imposes.

Released: December 07, 2021

Expiration: December 06, 2022

Share

Faculty

Latesha Elopre

Latesha Elopre, MD, MSPH

Associate Professor
Division of Infectious Diseases
Assistant Dean of Diversity and Inclusion
General Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Michael A. Fordham

Michael A. Fordham, BA

Program Administrator
Division of Infectious Diseases
Heersink School of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Latesha Elopre, MD, MSPH

Associate Professor
Division of Infectious Diseases
Assistant Dean of Diversity and Inclusion
General Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Latesha Elopre, MD, MSPH, has disclosed that she has received funds for research support from Merck.

Michael A. Fordham, BA

Program Administrator
Division of Infectious Diseases
Heersink School of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

Michael A. Fordham, BA, has no relevant conflicts of interest to report.